Health
Early monoclonal antibody therapies beneficial for COVID-19, finds study – News-Medical.Net
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB)…
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate coronavirus disease 2019 (COVID-19). The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19. The study is currently available on the medRxiv* preprint server.
Background
Since the emergence…
-
Noosa News22 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business15 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today